Cargando…
HPR118 An Updated Estimate of the Direct Cost of the COVID-19 Pandemic for the Greek Healthcare System
Autores principales: | Athanasakis, K, Nomikos, N, Kyriopoulos, I, Souliotis, K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747444/ http://dx.doi.org/10.1016/j.jval.2022.09.1248 |
Ejemplares similares
-
PNS21 From Disease Burden to Healthcare Cost: Highlighting the Health Economics Aspects of the COVID-19 Pandemic
por: Athanasakis, K., et al.
Publicado: (2020) -
Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting
por: Athanasakis, Kostas, et al.
Publicado: (2013) -
Estimates of price and income elasticity in Greece. Greek debt crisis transforming cigarettes into a luxury good: an econometric approach
por: Tarantilis, Filippos, et al.
Publicado: (2015) -
Antibacterial Treatment of Meticillin-Resistant Staphylococcus Aureus Complicated Skin and Soft Tissue Infections: a Cost and Budget Impact Analysis in Greek Hospitals
por: Athanasakis, Kostas, et al.
Publicado: (2014) -
Cost–Benefit Analysis of Single versus Repeated Use of Single-Use Devices in Cataract Surgery
por: Naoum, Panagiota, et al.
Publicado: (2021)